Back
Trxade Health 10K Form
Buy
59
MEDS
Trxade Health
Last Price:
5.75
Seasonality Move:
1.76%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MEDS News And Ratings
See the #1 stock for the next 7 days that we like better than MEDS
MEDS Financial Statistics
Sales & Book Value
| Annual Sales: | $8.27M |
|---|---|
| Cash Flow: | $-867.5K |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.60 |
| Price / Book: | 14.93 |
Profitability
| EPS (TTM): | -23.22000 |
|---|---|
| Net Income (TTM): | $-17.89M |
| Gross Margin: | $2.6M |
| Return on Equity: | -757.86% |
| Return on Assets: | -195.86% |
Trxade Health Earnings Forecast
Key Trxade Health Financial Ratios
- The Gross Profit Margin over the past 14 years for MEDS is 31.41%.
- The Selling, General & Administrative Expenses for MEDS have been equal to 102.57% of Gross Profit Margin.
- The Research & Development expenses have been 16.65% of Revenue.
- The Interest Expense is -6.72% of Operating Income.
- The Net Earning history of MEDS is -215.70% of Total Revenues.
- Per Share Earnings over the last 14 years have been positive in 5 years.
Trxade Health Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Technology |
| Sector: | Health Care |
| Current Symbol: | MEDS |
| Website: | trxadehealth.com |
Debt
| Debt-to-Equity Ratio: | 12.09 |
|---|---|
| Current Ratio: | 0.24 |
| Quick Ratio: | 0.23 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
MEDS Technical Analysis vs Fundamental Analysis
Buy
59
Trxade Health (MEDS)
is a Buy
Is Trxade Health a Buy or a Sell?
-
Trxade Health stock is rated a Buy
The current Trxade Health [MEDS] share price is $5.76. The Score for MEDS is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.